The company is a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions. Biostar chief executive officer and
Zaltrap is an angiogenesis inhibitor which inhibits the blood supply to tumors. FDA has approved Zaltrap following a Priority Review and a data collected from the pivotal Phase
The JV will develop a family of Apo E mimetic peptides licensed from The UAB Research Foundation (UABRF). Under the JV agreement, Capstone will contribute $6m, while LipimetiX
In a mouse model of PKD, treatment with a folate-conjugated form of rapamycin, FC-rapa, (EC0371) attenuated proliferation and growth of renal cysts and preserved renal function. Endocyte has
With the acquisition, all outstanding shares of HGS were acquired for $14.25 per share in cash. The 174,430,970 shares, which were tendered and were not withdrawn during the
HP802-247 is an investigational allogeneic living cell bioformulation that contains keratinocytes and fibroblasts currently under development for venous leg ulcers treatment. Healthpoint Biotherapeutics chief medical officer Bert Slade
iPS Academia Japan, an affiliate of Kyoto University, is engaged in managing and utilizing the patents and other intellectual properties in the field of iPSC technologies so that
The randomized, double-blind clinical trial is designed for evaluating Endocyte’s vintafolide drug in combination with DOXIL compared to DOXIL plus placebo for the treatment of folate-receptor positive platinum-resistant
ETI-204 is a humanized and deimmunized monoclonal antibody that targets the protective antigen of B. anthracis and neutralizes the lethal effects of anthrax toxins. Under the grant, Department
As part of the CRADA, the biomedical company will assess the safety and efficacy of Oxycyte, a perfluorocarbon-based drug candidate, as well as hemoglobin-based oxygen carriers (HBOC) as
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.